CYP11α (tttta)n microsatellite polymorphism in Korean patients with polycystic ovary syndrome.

被引：0
|
作者：
Kim, J [1 ]
Choi, Y [1 ]
Lee, G [1 ]
Kim, S [1 ]
Kim, J [1 ]
Moon, S [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Seoul 151, South Korea
来源：
FERTILITY AND STERILITY | 2005年 / 84卷
关键词：
D O I：
10.1016/j.fertnstert.2005.07.1102
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S421 / S422
页数：2
相关论文
共 50 条
  • [21] Fasting proinsulin concentrations in patients with polycystic ovary syndrome.
    Bravo, FAP
    Maliqueo, M
    Angel, B
    Petermann, TS
    DIABETOLOGIA, 2002, 45 : A144 - A144
  • [22] Evaluation of Gallbladder Motility in Patients with Polycystic Ovary Syndrome.
    Isik, S.
    Ozcan, H. N.
    Berker, D.
    Tutuncu, Y.
    Ozuguz, U.
    Akbaba, G.
    Guler, S.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [23] Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome
    Ferk, Polonca
    Perme, Maja Pohar
    Teran, Natasa
    Gersak, Ksenija
    FERTILITY AND STERILITY, 2008, 90 (03) : 860 - 863
  • [24] Telomere Maintenance is Altered in Patients Diagnosed with Polycystic Ovary Syndrome.
    Cordova-Oriz, Isabel
    Delgado-Sanchez, Ivan
    S-Mellado, Lucia Sanchez
    Polonio, Alba M.
    Chico-Sordo, Lucia
    Medrano, Marta
    Rodriguez-Garcia, Angela
    Madero-Molina, Maria
    Garcia-Velasco, Juan A.
    Varela, Elisa
    REPRODUCTIVE SCIENCES, 2024, 31 : 324A - 324A
  • [25] Underutilization of Metabolic Screening Studies in Patients With Polycystic Ovary Syndrome.
    Dhesi, Amy S.
    Lim, Jonathan K.
    Solnica, Amy
    McGovern, Peter G.
    REPRODUCTIVE SCIENCES, 2015, 22 : 312A - 312A
  • [26] Metformin reverses anovulation in hyperinsulinemic patients with polycystic ovary syndrome.
    Väli, M
    Rull, K
    DIABETOLOGIA, 2000, 43 : A185 - A185
  • [27] The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome
    Ferk, Polonca
    Teran, Natasa
    Gersak, Ksenija
    HUMAN REPRODUCTION, 2007, 22 (04) : 1031 - 1036
  • [28] The (TTTA)n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population
    P. Xu
    X. L. Zhang
    G. B. Xie
    C. W. Zhang
    S. M. Shen
    X. X. Zhang
    Y. X. Cao
    W. J. Wang
    Y. N. Che
    Y. J. Xia
    X. K. Wu
    L. Yi
    Q. Gao
    Y. Wang
    Molecular Biology Reports, 2013, 40 : 5041 - 5047
  • [29] The (TTTA) n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population
    Xu, P.
    Zhang, X. L.
    Xie, G. B.
    Zhang, C. W.
    Shen, S. M.
    Zhang, X. X.
    Cao, Y. X.
    Wang, W. J.
    Che, Y. N.
    Xia, Y. J.
    Wu, X. K.
    Yi, L.
    Gao, Q.
    Wang, Y.
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (08) : 5041 - 5047
  • [30] Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
    Hong, J. S.
    Kwon, H. H.
    Park, S. Y.
    Jung, J. Y.
    Yoon, J. Y.
    Min, S.
    Choi, Y. M.
    Suh, D. H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (01) : 42 - 47
12345